Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elamipretide in Advanced Symptoms of Friedreich Ataxia
NCT05168774Phase 2Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Mar 2022
- Primary completion
- Jun 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elamipretide in Friedreich ataxia (FA), sponsored by Children's Hospital of Philadelphia. Started Mar 2022; status: completed.
02
Drugs
elamipretide
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT05168774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05168774.